According to Global Blood Therapeutics 's latest financial reports the company's current revenue (TTM ) is ₹20.32 Billion. In 2021 the company made a revenue of ₹14.49 Billion an increase over the revenue in the year 2020 that were of ₹9.05 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.